×

Enthused about Indigenous Medical Scholarship

It is pretty hard to imagine someone being more inspirational than Associate Professor Kelvin Kong.

Australia’s first Indigenous surgeon – having qualified as the first Aboriginal Fellow of the Royal Australasian College of Surgeons and specialising in otolaryngology, head and neck surgery – he is passionate about bridging the health gap between Indigenous and non-Indigenous Australians.

Hailing from the Worimi people of Port Stephens, he now practices paediatric and adult ear, nose and throat surgery at Newcastle, NSW. He also lectures there.

His career to date is impressive and he is hugely committed to helping others pursue their own goals. Describing Dr Kong as enthusiastic would be an understatement.

Included in his long list of accolades is the AMA Indigenous Medical Scholarship.

A young Kelvin was the scholarship’s recipient in 1997.

Australian Medicine asked Dr Kong how important it was then to receive the award and how it seems now in retrospect.

“At the time it was extremely important,” he said.

“It wasn’t a huge amount of money, but for me it was. It certainly wasn’t a little amount of money, but I wouldn’t have cared if it was five bucks.

“The biggest impact it had on me was being recognised by my colleagues and the medical fraternity as someone who is legitimate.

“I was being told that I can make a contribution. I stand very proud as a recipient of this scholarship. I hope it has paid off and I hope those who sponsored it believe their contribution was worthwhile.

“I was mid-career with my studies, year 3-4, and at a time when we are pouring beers, waiting tables and all that kind of stuff just trying to get through.

“This meant I could pay my bills and put food on the table and spend more time trying to feel normal.

“It is important in retrospect to acknowledge the pure fact that the AMA thought that this was a big enough issue to get its Board to recognise and seek to fund.

“That was huge. It says a lot about the AMA as an organisation that it had that vision.

“Medicine is hugely competitive, so to get some acknowledgement is very important. It gave me a lot of inroads into mentorship and leadership and allowed me to contact people with similar values to me.

“Australia is a diverse community and so is its medical community. This was normalising that it’s ok to achieve.

“In the Aboriginal community and in the wider community there can be this misconception that people are ‘getting in’ on the back of them being Aboriginal. The actual fact is, there are a lot of hugely talented people in the Aboriginal community who will make an enormous contribution to medicine.

“That was a great vision and I am eternally grateful for being given that morale boost.”

Dr Kong has used his scholarship, and all of the honours that followed, to help him play his part in addressing the disparity – not only in health outcomes, but in career opportunities – between Indigenous and non-Indigenous Australians.

“It is important to acknowledge the disparity of opportunities for people who live in the same country,” he said.

“We have a very robust medical industry. I know there is talk of maybe awarding two of these scholarships each year. I think it would be fabulous if there were ten.

“I was asking myself ‘how can the AMA enhance this more?’ and I thought that maybe one way is by increasing the number of scholarships – increasing the number of donors.

“There is a greater awareness among Australia and the medical community that this is genuinely important and we give value to it. It gives me that boost. It must give donors that boost too.

“We have this disparity in health outcomes, but there is a genuine desire in governments, in associations like the AMA, and in the community to address this.

“I am extremely lucky, first and foremost. I love my profession. I love my work. I love coming to work.

“As a Worimi man, I am heartened that we are as an Australian community seeking to address this disparity.

“I live a fantastic lifestyle. But my mother never had this opportunity, my Nan never had this opportunity.

“They would have done a better job.”

He says with a smile.

CHRIS JOHNSON

 Information about donations towards the Indigenous Medical Scholarship can be found at: donate-indigenous-medical-scholarship

 

 

 

Coordinated approach needed to improve Indigenous ear health

Ear health is the focus of the 2017 AMA Indigenous Health Report Card, with doctors calling on all Governments to works towards ending chronic otitis media.

Releasing the Report Card in Canberra on November 29, AMA President Dr Michael Gannon challenged the Federal Government and those of the States and Territories to work with health experts and Indigenous communities to put an end to the scourge of poor ear health affecting Aboriginal and Torres Strait Islanders.

The Report’s focus on ear health was part of the AMA’s step by step strategy to create awareness in the community and among political leaders of the unique health problems that have been eradicated in many parts of the world, but which still afflict Indigenous Australians.

“It is a tragedy that in 21st century Australia, poor ear health, especially chronic otitis media, is still condemning Indigenous people to a life sentence of hearing problems – even deafness,” Dr Gannon said.

“Chronic otitis media is a disease of poverty, linked to poorer social determinants of health including unhygienic, overcrowded conditions, and an absence of health services.

“It should not be occurring here in Australia, one of the world’s richest nations. It is preventable.

“Otitis media is caused when fluid builds up in the middle ear cavity and becomes infected.

“While the condition lasts, mild or moderate hearing loss is experienced. If left untreated, it can lead to permanent hearing loss.”

Dr Gannon said that for most non-Indigenous Australian children, otitis media is readily treated, but for many Aboriginal and Torres Strait Islander children, it is not.

Estimates show that an average Indigenous child will endure middle ear infections and associated hearing loss for at least 32 months, from age two to 20 years, compared with just three months for a non-Indigenous child.

The Report Card, A National Strategic Approach to Ending Chronic Otitis Media and its Life Long Impacts in Indigenous Communities, was launched in Parliament House by Indigenous Health Minister Ken Wyatt

Mr Wyatt commended the AMA on its 2017 Report Card.

Over the past 15 years, he said, the AMA’s annual Report Card on Indigenous Health has highlighted health priorities in Australia’s Aboriginal peoples and communities.

“Reports can be daunting and they can be challenging,” the Minister said.

“But above all, they can be inspiring.”

Mr Wyatt said it was a tragedy that the most common of ear infections and afflictions were almost entirely preventable.

Yet left untreated in Indigenous children, they had lifelong effects on education, employment and well-being.

“It’s not somebody else’s responsibility. It’s the responsibility of all of us,” he said.

“Hearing is fundamental.”

Shadow Indigenous Health Minister Warren Snowdon also commended the AMA on its report.

He said the Government and the Opposition worked collaboratively on Indigenous health issues.

“We’re not interested in making this a point of political difference, we’re interested in making it a national priority,” he said.

Green’s Indigenous Health spokeswoman Senator Rachel Siewert welcomed the Report and stressed the importance of addressing Indigenous health issues.

Australia’s first Indigenous surgeon, ear, nose and throat specialist Dr Kelvin Kong, who is also the Chair of the Australian Society of Otolaryngology Head and Neck Surgery’s Aboriginal Health Subcommittee, received the report with enthusiasm.

He said cross-party support on this issue had been “phenomenal”.

Dr Gannon said the AMA wants a national, systematic approach to closing the gap in the rates of chronic otitis media between Indigenous and non-Indigenous infants and children in Australia.

The Report calls on Governments to act on three core recommendations: namely, that a coordinated national strategic response to chronic otitis media be developed by a National Indigenous Hearing Health Taskforce under Indigenous leadership for the Council of Australian Governments (COAG); that the wider impacts of otitis media-related developmental impacts and hearing loss, including on a range of areas of Indigenous disadvantage such as through the funding of research as required are addressed; and that attention of governments be re-directed to the recommendations of the AMA’s 2015 Indigenous Health Report Card, which called for an integrated approach to reducing Indigenous imprisonment rates by addressing underlying causal health issues.

“We urgently need a coordinated national response to the lasting, disabling effects and social impacts of chronic otitis media in the Indigenous adult population,” Dr Gannon said.

The AMA Indigenous Health Report Card 2017 A National Strategic Approach to Ending Chronic Otitis Media and its Life Long Impacts in Indigenous Communities can be found at article/2017-ama-report-card-indigenous-health-national-strategic-approach-ending-chronic-otitis

 CHRIS JOHNSON

The quick fix that dramatically cuts antibiotic use

 

Simply asking patients to wait a couple of days to see if their symptoms resolve before filling their script substantially cuts antibiotic use, an Australian meta-analysis has found.

The Cochrane review, led by the University of Queensland’s Primary Care Clinical Unit, looked at 11 studies involving 3,500 patients with suspected common respiratory tract infections. It essentially found no significant clinical difference in outcomes between patients randomised to immediate prescription of antibiotics, delayed prescription, or no prescription.

There were also very low rates of complications or missed treatment of serious complications in those randomised to the ‘wait-and-see’ prescriptions.

But delaying prescription led to a massive drop in antibiotic use. Over 90% of patients with an immediate prescription filled it, compared with around 30% of those with a delayed prescription.

Patients were more satisfied with being given a delayed prescription compared with being given no prescription at all – a significant finding since it’s well recognised that some of the pressure to prescribe antibiotics comes from the patients themselves.

The studies reviewed involved acute respiratory tract infections, including cough, sore throat, colds and otitis media.

Lead author Dr Geoffrey Spurling said the review showed delayed prescribing could be an acceptable compromise if a doctor didn’t believe antibiotics were needed at the time of the consult, but was uneasy about adopting a ‘no-antibiotics’ approach.

“The evidence indicates that delayed prescribing is an effective strategy for reducing antibiotic use and now we need to get this message out the medical community,” he said. “Individual GPs can feel confident implementing this strategy for reducing antibiotic use as a way of treating infections if they are uncomfortable with not prescribing antibiotics.”

As outlined in research recently published in the MJA, Australia has a very high rate of prescribing antibiotics for respiratory tract infections, with antibiotics prescribed at 4-9 times more often than is recommended by therapeutic guidelines.

Australia’s Chief Medical Officer recently sent written warnings to the top 30% of antibiotic prescribers, asking them to think about what they can do to reduce their prescribing.

You can access the Cochrane Review here.

Northern Territory Remote Aboriginal Investment: Ear and Hearing Health Program—July 2012 to June 2016

This report presents data on the Indigenous children and young people who participated in the audiology, ear, nose and throat (ENT) teleotology and Clinical Nurse Specialist (CNS) services delivered under the National Partnership Agreement on Northern Territory Remote Aboriginal Investment. During 2012–16, 9,221 outreach audiology services were provided to 5,357 children and young people, and 3,799 ENT teleotology services to 2,434 children and young people. A total of 2,612 children participated in the CNS services and presented for 3,085 visits. Of the children and young people who received audiology services in 2015–16, 31% had a hearing impairment.

Neurofibromatosis of the tongue

A 45-year-old woman presented with a painless mass in the tongue that had grown gradually over the past 20 years (Figure, arrowheads). She had café-au-lait spots and previous neurofibroma resections. Neurofibromatosis type 1 was also found in her father and two children. Recent speech problems made a resection necessary. Partial removal of the mass immediately improved communication. Pathological analysis showed plexiform neurofibroma without malignant transformation. Neurofibromatosis type 1 is an autosomal dominant disorder characterised by neurofibromas that can potentially affect every site of the body. Malignant transformation is rare and resection is indicated when functional or aesthetic impairment is associated.1

Figure

Warnings for GPs over usage of flu vaccine in children

The Royal Australian College of General Practitioners has warned its members to be wary when administering the influenza vaccine to children under 5.

In a member communication, they have confirmed that there have been off-label usage of influenza vaccines Fluarix Tetra and Fluvax which poses a safety risk for children.

The RACGP says the GSK Fluarix Tetra is being incorrectly administered to children under 3 years (including half doses of the vaccine). The vaccine isn’t registered for this age group.

The Seqirus’ (BioCSL) Fluvax is also being incorrectly administered to children.

Related: Flu vaccine more effective in the morning: study

According to the Influenza Fact sheet from the Department of Health:

FluQuadri Junior® (Sanofi Pasteur) is for children from six months to under three years of age is presented in a 0.25 mL pre-filled syringe.

Fluarix® Tetra (GSK) for people aged three years and older is presented in a 0.5 mL pre-filled syringe.

In order to minimise vaccination accidents, the RACGP recommends:

  • Ensure children’s vaccines are quarantined and clearly labelled in the vaccine fridge
  • Ensure two clinical staff check each vaccine before administration
  • Read the Australian Technical Advisory Group’s statement on influenza vaccines
  • Discuss with your practice about practical steps to ensure patients receive the correct vaccine every time.

Latest news:

Sudden sensorineural hearing loss secondary to metronidazole ototoxicity

A 30-year-old Indian gentleman presented to the emergency department of the Royal Victorian Eye and Ear Hospital, Melbourne, with a history of bilateral profound deafness, tinnitus and headache associated with upper- and lower-limb paraesthesia and myalgia. He had been taking metronidazole (400 mg tds) and amoxycillin (500 mg tds) over the preceding 4 days to treat gingivitis. Further questioning revealed that his maternal uncle had experienced identical symptoms while taking metronidazole. Consequently, his metronidazole was immediately discontinued.

After 2 days, he was able to hear faint sounds, and audiography revealed a symmetrical moderate-to-profound sensorineural hearing loss (SNHL) (Box, A). As per our hospital protocol for SNHL management, oral prednisolone was administered (50 mg daily), followed by a slow wean over 3 weeks.

After 8 days, subjective hearing and paraesthesia had improved, and his headache had abated. Audiometry indicated moderate SNHL up to 2000 Hz, with persisting severe high-frequency SNHL (Box, B).

At 6 weeks, repeat audiogram indicated that hearing was normal up to 2000 Hz, but severe-to-profound high-frequency SNHL persisted (Box, C).

Metronidazole is a nitroimidazole antibiotic widely used in various medical specialties. Common side effects include nausea, diarrhoea and abdominal discomfort. Patients receiving high or intravenous doses may experience neurotoxicity, but it is uncommon to suffer ototoxicity.

The first documented case of metronidazole-induced ototoxicity was reported in 1984.1 Since then there have been infrequent but typical reports of SNHL associated with metronidazole. In 1999, two cases of SNHL following about 2 days of treatment with metronidazole for dental sepsis were described.2 More recently, sudden bilateral SNHL after 4 days of metronidazole treatment for diarrhoea has been reported.3

We can only speculate about the mechanism of metronidazole-induced ototoxicity. The clear familial link in our case suggests a potential genetic susceptibility, similar with other ototoxic agents, such as susceptibility for the ototoxic effects of aminoglycosides associated with the mitochondrial A1555G deletion.

Several neurotoxic effects of metronidazole have been hypothesised, including toxic excitation of NMDA receptors leading to production of free radicals and cell death, as well as effects on GABAergic transmission and direct RNA-binding effects.4 Whether or not there is a genetic susceptibility for its effects has not yet been investigated, but it is reported that the onset of neurotoxicity is more rapid and occurs at lower doses in patients of Indian descent than in those of European origin.5

In conclusion, metronidazole is a known neurotoxic antibiotic that can be ototoxic, if only rarely. These adverse effects are reversible after withdrawing the drug. Given its widespread use, it is important that prescribers are aware of these severe adverse reactions.

 


A: Initial audiogram, showing profound bilateral sensorineural deafness. B: Audiogram, 8 days after cessation of metronidazole, showing improvement in pure tone audiometry at frequencies up to 2000 Hz. C: Audiogram, 6 weeks after cessation of metronidazole, showing near-normal hearing at frequencies up to 2000 Hz, with severe high-frequency hearing loss.

The Sydney siege: courage, compassion and connectedness

To the Editor: Raphael and Burns highlighted the strong police response to the hostage situation in Sydney in 2014.1 Diversionary devices, such as the flash-bang grenades used in Sydney, have been increasingly used to distract and disorientate people in civilian hostage and riot situations internationally. While not intended to cause permanent damage, there are risks associated with their use.

Flash-bang grenades deflagrate using a powdered blend of aluminium, magnesium and ammonium perchlorate, which generates a spontaneous explosion. When initiated, illumination is produced through oxidation of the components, resulting in heat exceeding 38°C, a blast reaching 180 decibels and a brief flash of 1–6 million candela (up to 600 million lux) within a distance of about 1.8 m.2

The intense flash results in temporary bleaching of the photoreceptors in the eye. Ocular injury can occur if the flash-bang grenade explodes at close range, with possible thermal or mechanical damage. Other more powerful devices, producing a similar intensity of unidirectional light, have resulted in vision loss similar to that seen with laser weapons.2

Temporary hearing loss and aural pain results from a single or multiple blast of loud noise between 140 and 170 decibels. Damage to the sensitive structure of the inner and middle ear can result in hearing loss and tinnitus.3 Perilymphatic fistula of the inner ear may occur, necessitating immediate assessment and possible surgical treatment.4

Premature deflagration can also cause injury to the operator.5 As these devices continue to be used in civilian situations, it is important to remain aware of any potential hazards, to both the operator and bystanders.

Consent, capacity and the right to say no

Case study

A 74-year-old Sicilian woman was admitted to hospital with stridor and dysphonia in the setting of concurrent upper respiratory tract infection. This was on a background of toxic multinodular goitre that had been treated for 8 years with propylthiouracil, as she had reacted adversely to carbimazole. She had been recommended surgery in the past, but had declined.

Clinical examination revealed an obvious stridor and a diffuse, symmetrically large goitre. Pemberton sign was positive. Thyroid function tests had demonstrated a suppressed thyroid-stimulating hormone level (0.03 mU/L; reference interval [RI], 0.5–4.0 mU/L), with a free thyroxine level within the RI (16.3 pmol/L; RI, 10.0–19.0 pmol/L). Ultrasound and computed tomography imaging identified a large, retrosternal, multinodular goitre. Her trachea was significantly compressed, with a diameter of 5.5 mm (Box). We further recommended total thyroidectomy, which she again politely declined.

The night after admission, her condition deteriorated acutely and she was transferred to the intensive care unit with respiratory distress. The need for intubation was avoided and she was sufficiently managed with nebulised adrenaline and intravenous dexamethasone. Again, she refused surgery.

She remained in intensive care for the following week, with extensive discussion involving her family (two sons) and the help of Italian interpreters. She was seen by multiple doctors, including senior endocrine surgeons, ear, nose and throat surgeons, intensivists and anaesthetists, all of whom attempted to convey to her the need for surgery. It was made clear that without surgery, she would almost certainly die from tracheal obstruction.

The reasons for her refusal were several, but simple. In her native Sicily, a scar on one’s neck — the Sicilian bowtie — references the Mafia practice of throat-slitting and depicts the scar-carrier as dishonourable. She also expressed her fears of the risks of surgery, particularly voice changes from recurrent laryngeal nerve injury and the need for lifelong medication with thyroxine following thyroidectomy. Further, she was convinced that the reason for her stridor was her upper respiratory tract infection rather than tracheal compression, and believed that it would improve with time.

During this time, every practitioner regarded her to be competent to make this decision. She had an unconventional attitude towards life and death and the implications of surgery, and did not appear to have any cognitive impairment affecting her capacity to consent to or refuse intervention.

Because of the gravity and implication of her decision, we sought a neuropsychological assessment to formally document her capacity before discharge. Much to the surprise of all practitioners involved, the assessment deemed the patient incompetent to make her own decisions regarding treatment. She was assessed as having underlying cognitive impairment and impaired aspects of executive function. With regard to decision making, the assessment found that although “she could state the risks and consequences, she was not adequately and rationally weighing these up against the benefits”. We discussed the assessment with a senior neuropsychologist, who agreed with the initial assessment without any need for reassessment.

We sought advice from the hospital’s legal counsel, who recommended that, because the patient was deemed incompetent, the treatment decision should rest with her sons. In addition, the legal counsel considered neuropsychology to be the most expert opinion in competence assessment and, as such, no further assessment was warranted. Although keen for surgery, her sons were also aware of the implications of forcing their mother into an operation that she did not want. They would have to live with her anger or disappointment long after the acute surgical issues had passed.

After about a week of consideration, her sons consented to surgery. The patient was not informed for fear of an angry outburst leading to sudden airway compromise. Given the patient’s potentially difficult airway and her non-compliance, extensive anaesthetic planning ensued. An anaesthetic team of two senior anaesthetists and an anaesthetic nurse took a difficult airway trolley to the ward, where a heavily sedating premedication was administered and the patient was transferred to theatre. Total thyroidectomy was completed without complication, and the patient made a good postoperative recovery. She was grateful for our care and satisfied with the outcome. She was discharged 2 days later with no stridor, normal voice and normal parathyroid function.

Discussion

This case presented challenging and interesting medicolegal and social dilemmas. We were confronted by a patient with a serious, life-threatening but very treatable medical problem, who was refusing treatment. Moreover, all clinicians involved felt that she had capacity to make this decision, yet the neuropsychological assessment showed otherwise.

Legally, “capacity” and “competence” are interchangeable. At common law, adults are always presumed to be competent, unless it can be proved that they lack competence.1 The test at common law for competence is functional; that is, whether they have the ability to make the decision rather than basing it on criteria or “reasonableness”.2 Generally, the law requires that the patient be able to understand and retain treatment information, believe the information, weigh the information and reach a decision, and communicate his or her decision.1

Based on this common law approach, four jurisdictions in Australia (New South Wales, Queensland, Tasmania and Victoria) have enacted legislation which adopts a functional test of competence.1 In Victoria (the location of this case), s 36(2) of the Guardianship and Administration Act 1986 states:

a person is incapable of giving consent to the carrying out of a special procedure or medical or dental treatment if the person —

(a) is incapable of understanding the general nature and effect of the proposed procedure or treatment; or

(b) is incapable of indicating whether or not he or she consents or does not consent to the carrying out of the proposed procedure or treatment.

Despite the apparent clarity of the legislation, the Victorian Office of the Public Advocate recognises that an assessment of competence is not always straightforward and may require input from specialists such as neuropsychologists, psychiatrists and geriatricians.3 Assessment of competence can often be fraught with complexity. Of patients with underlying mild–moderate cognitive impairment, about 60% of patients remain undiagnosed, even by family members.4 Further, a cognitive test such as the Mini-Mental State Examination has flaws — it is culture-specific and does not address individual cognitive domains well. Complicating this further, acute illness and medication impairs patients’ abilities to synthesise information. The law, as a result of these inherent difficulties in establishing competence, does not require any specific test to be passed, but instead leaves the decision to the discretion of the clinician.1

In cases of incompetent patients, treatment decisions are made by a substitute decisionmaker — a guardian, a medical power of attorney or a person responsible (in our case, the patient’s elder son). In arriving at the treatment decision, the substitute decisionmaker has a responsibility to satisfy either one of two legal standards. The best interest standard involves making a decision in what is considered to be the patient’s best interest (often used for children). The substituted judgment standard relates to patients like ours, who have previously voiced their preference for treatment. Under this test, decisionmakers should attempt to reach the same decision that the patient would have reached had they remained competent.4

Our patient had refused surgery for her thyroid for 8 years before her presentation. She was considered to have capacity then and was never thought to warrant neuropsychological assessment earlier. The substituted judgment standard would suggest that her son should have had this in mind when considering the appropriate treatment approach now.

There has been debate in law about whether some decisions require more competence than others. The prevailing view is that “the more serious the risk, the greater the level of evidence of capacity that should be sought”.4 Some patients may be competent to consent to minor procedures like vaccinations but not competent to consent to major surgery. Unfortunately, there is no guide for doctors to evaluate the level of evidence of competence required for any one particular procedure.

What about our situation, where a patient is judged by doctors as having capacity but by a neuropsychologist as not? When should doctors be satisfied with their own evaluation and under what circumstances should a specialist be engaged on the basis that a higher level of evidence of competence needs to be demonstrated? The law would suggest that specialists in competence assessment (eg, neuropsychologists) should be employed when there is doubt and the consequences are severe. In our case, the patient was considered competent by multiple clinicians. It was only because of the risk of death without surgery that our patient underwent a neuropsychological assessment; many saw this as being an unnecessary step, given her apparent competence. Nevertheless, the severe consequences of inaction justified a comprehensive assessment of competence.

This case also highlights the blurred boundary between capacity and rationality. Our neuropsychologist identified a lack of rationality as one of the reasons for our patient’s incompetence. However, our legislated definition of capacity (stated above) only requires that patients understand; it does not require an assessment of what is rational. Regarding rationality, the Stanford encyclopedia of philosophy states that a “theory of decisional capacity must allow for the fact that health care subjects can make unpopular decisions, even ones that are considered highly irrational by others”.5 Patients must be afforded the right to make seemingly irrational decisions, provided they can understand and appreciate the consequences. An analogy could be made to a Jehovah’s Witness refusing a life-saving blood transfusion; highly irrational to many, this choice is honoured by doctors.

In medicine, we regularly see patients who refuse our recommended treatment. Should we be requesting neuropsychological assessment of all patients refusing our recommendations on the basis that they might be “incapable of understanding the general nature and effect of the proposed procedure or treatment”, as set out in the Victorian Guardianship and Administration Act? To what extent can differences in cultural values cloud the question of whether a patient truly understands the treatment?

These sorts of questions create doubt in the process of assessing capacity and put enormous pressure on doctors making assessments. There is conflict between the doctor’s duty to do what he or she considers to be in the patient’s best interests, while also allowing the patient to make decisions that the doctor considers to be “irrational”. Regarding this conflict, however, the law seems to be clear. In a United Kingdom case, the presiding judge stated: “The doctors must not allow their emotional reaction to or strong disagreement with the decision of the patient to cloud their judgment in answering the primary question whether the patient has the mental capacity to make the decision”.6

Despite her initial reluctance, our patient was happy with her postoperative outcome. We feel that our process was robust and that the appropriate decision was made. But there was still significant unease among the team members that we were operating on a patient against her will. And her satisfaction postoperatively should not be misconstrued as proof that we did the right thing. The right thing is to ensure that a patient’s autonomy is maintained and that we do not confuse our own prejudices with patient competency.

We must remember the social implications of our decisions and interventions. It is not acceptable to consider only the medical issues. Our patients all have unique social circumstances, and our treatments can impact heavily upon these. If our patient refused to speak again to her sons as a result of them consenting to surgery that she had refused, could we consider this a successful outcome?

This case has displayed the many complexities inherent in the assessment of a patient’s capacity to consent to or refuse treatments and interventions. Many social, cultural and legal factors may need to be considered. As clinicians, our understanding of some of these subtleties is limited. Legal principles are complicated and often cases need to be considered carefully on individual merits. Resources such as hospital legal counsel, the Office of the Public Advocate or Guardian (depending on the jurisdiction) and medicolegal handbooks are invaluable in ensuring the protection of both the patient and doctor. In the process of writing this article, our research answered several of the legal questions we had encountered — the answers are available to clinicians if we know where to look. Our experience has taught us to employ the services of multiple teams — medical, psychological and legal — and to engage family in the decision-making process.

Computed tomography scan, showing retrosternal goitre with tracheal compression

Dysphagia, regurgitation and weight loss in an elderly man

An 84-year-old man reported unintentional weight loss of 15 kg over 18 months and dysphagia and regurgitation of undigested food over 3 months. Barium swallow showed a large pharyngo-oesophageal (Zenker) diverticulum. These are caused by elevated intraluminal pressure at the Killian dehiscence, an area of hypopharyngeal weakness between the cricopharyngeus and inferior pharyngeal constrictors.

Zenker diverticuli are rare, but can cause significant morbidity and mortality. A barium swallow should precede gastroscopy, as there is a risk of perforation and mediastinitis. We performed endoscopic stapling, as it is less invasive than open repair.